08:35 AM EDT, 08/05/2024 (MT Newswires) -- Krystal Biotech ( KRYS ) said Monday it swung to Q2 earnings of $0.53 per diluted share, from a loss of $1.25 per share a year earlier.

Analysts polled by Capital IQ expected earnings of $0.59.

Net revenue for the quarter ended June 30 was $70.3 million. The biotech company did not report revenue in the year-ago quarter.

Analysts polled by Capital IQ expected $65.5 million.

Price: 170.00, Change: -21.94, Percent Change: -11.43